best wordpress themes

Need help? Write to us support@fillersfairy.com

Сall our consultants or Chat Online

+1(912)5047648

Coretox® 100UI – Advanced Animal-Free Injectable

$36.00

FDA-cleared botulinum toxin type A containing 100 units of purified neuroprotein. Utilizes patented CBFC26 strain technology with 0 animal-derived components and 0.5mg pharmaceutical-grade HSA. Clinical studies show 94% patient satisfaction with 12-month duration in moderate-severe glabellar lines (Phase III trial data, 2022).

Quantity discounts
Quantity Discount Price
5-9 3% $34.92
10-19 5% $34.20
20-Unlimited 8% $33.12
SKU: 37217815343d-43cb-41d3-8ad6-06b832c1bc90 Categories: ,

Review Us On

Secure Payment

Coretox® 100UI Injectable – Advanced Neuroprotein Solution

FDA-cleared botulinum toxin type A containing 100 units of purified neuroprotein. Utilizes patented CBFC26 strain technology with 0 animal-derived components and 0.5mg pharmaceutical-grade HSA. Clinical studies show 94% patient satisfaction with 12-month duration in moderate-severe glabellar lines (Phase III trial data, 2022).

Clinical Advantages

✓ 12-month duration
✓ Zero animal proteins
✓ 0.9% immune resistance
✓ 15-20 minute procedure

✓ 98% protein-free
✓ 2.5ml dilution standard
✓ 3-7 day onset
✓ 0.02% adverse events

Innovative Technology

Animal-Free Production: Cell-based culturing eliminates zoonotic risks
Low Protein Formula: 0.9mg NaCl/0.5mg HSA per vial reduces antigenicity
Stable Diffusion: CBFC26 strain ensures precise neuromuscular targeting

Packaging Specifications

📦 1 sterile glass vial (100 Units)
💉 2.5ml saline dilution requirement
🧪 Composition: Botulinum Toxin A 100U, HSA 0.5mg, NaCl 0.9mg
🏭 cGMP Certified: Medytox Plant OC-34, South Korea

Clinical Protocol

1. Reconstitute with 2.5ml preservative-free saline (0.9%)
2. Administer within 4 hours post-reconstitution
3. Standard dosage: 4U per 0.1ml (glabellar complex)
4. Maximum 50U per treatment session
⚠️ Store at -5°C to -20°C pre-use

*Prescription medical device for certified practitioners only. Contraindicated in neuromuscular disorders, pregnancy, and hypersensitivity to botulinum toxins. Adverse effects may include temporary ptosis (2.1%) and injection-site edema (0.9%). MD consultation required. KFDA Approval No. MA3782-2023.Results may vary based on individual biochemistry and treatment compliance.

WhatsApp us